These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 11341460)
1. Prophylactic and acute treatment with the homeopathic medicine, Betula 30c for birch pollen allergy: a double-blind, randomized, placebo-controlled study of consistency of VAS responses. Aabel S Br Homeopath J; 2001 Apr; 90(2):73-8. PubMed ID: 11341460 [TBL] [Abstract][Full Text] [Related]
2. Is homeopathic 'immunotherapy' effective? A double-blind, placebo-controlled trial with the isopathic remedy Betula 30c for patients with birch pollen allergy. Aabel S; Laerum E; Dølvik S; Djupesland P Br Homeopath J; 2000 Oct; 89(4):161-8. PubMed ID: 11055772 [TBL] [Abstract][Full Text] [Related]
3. No beneficial effect of isopathic prophylactic treatment for birch pollen allergy during a low-pollen season: a double-blind, placebo-controlled clinical trial of homeopathic Betula 30c. Aabel S Br Homeopath J; 2000 Oct; 89(4):169-73. PubMed ID: 11055773 [TBL] [Abstract][Full Text] [Related]
4. The safety and efficacy of subcutaneous birch pollen immunotherapy - a one-year, randomised, double-blind, placebo-controlled study. Bødtger U; Poulsen LK; Jacobi HH; Malling HJ Allergy; 2002 Apr; 57(4):297-305. PubMed ID: 11906359 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis. Kuehr J; Brauburger J; Zielen S; Schauer U; Kamin W; Von Berg A; Leupold W; Bergmann KC; Rolinck-Werninghaus C; Gräve M; Hultsch T; Wahn U J Allergy Clin Immunol; 2002 Feb; 109(2):274-80. PubMed ID: 11842297 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis. Pauli G; Larsen TH; Rak S; Horak F; Pastorello E; Valenta R; Purohit A; Arvidsson M; Kavina A; Schroeder JW; Mothes N; Spitzauer S; Montagut A; Galvain S; Melac M; André C; Poulsen LK; Malling HJ J Allergy Clin Immunol; 2008 Nov; 122(5):951-60. PubMed ID: 19000581 [TBL] [Abstract][Full Text] [Related]
10. Environmental exposure unit simulates natural seasonal birch pollen exposures while maximizing change in allergic symptoms. Ellis AK; DeVeaux M; Steacy L; Ramesh D; Suprun M; Langdon S; Wang CQ; Adams D; Thiele J; Walker T; Perlee LT; O'Brien MP Ann Allergy Asthma Immunol; 2021 Oct; 127(4):488-495.e5. PubMed ID: 34186172 [TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, placebo-controlled exploratory study to evaluate the potential of pycnogenol for improving allergic rhinitis symptoms. Wilson D; Evans M; Guthrie N; Sharma P; Baisley J; Schonlau F; Burki C Phytother Res; 2010 Aug; 24(8):1115-9. PubMed ID: 20549654 [TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study. Khinchi MS; Poulsen LK; Carat F; André C; Hansen AB; Malling HJ Allergy; 2004 Jan; 59(1):45-53. PubMed ID: 14674933 [TBL] [Abstract][Full Text] [Related]
13. Lack of effect of Timothy grass pollen sublingual immunotherapy tablet on birch pollen-induced allergic rhinoconjunctivitis in an environmental exposure unit. Ellis AK; Tenn MW; Steacy LM; Adams DE; Day AG; Walker TJ; Nolte H Ann Allergy Asthma Immunol; 2018 May; 120(5):495-503.e2. PubMed ID: 29432967 [TBL] [Abstract][Full Text] [Related]
15. Preseasonal local allergoid immunotherapy to grass pollen in children: a double-blind, placebo-controlled, randomized trial. Caffarelli C; Sensi LG; Marcucci F; Cavagni G Allergy; 2000 Dec; 55(12):1142-7. PubMed ID: 11117271 [TBL] [Abstract][Full Text] [Related]
16. Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate. Pajno GB; Vita D; Parmiani S; Caminiti L; La Grutta S; Barberio G Clin Exp Allergy; 2003 Dec; 33(12):1641-7. PubMed ID: 14656349 [TBL] [Abstract][Full Text] [Related]
17. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis. Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092 [TBL] [Abstract][Full Text] [Related]
18. Sublingual immunotherapy with a standardised grass pollen extract; a double-blind placebo-controlled study. Hordijk GJ; Antvelink JB; Luwema RA Allergol Immunopathol (Madr); 1998; 26(5):234-40. PubMed ID: 9885731 [TBL] [Abstract][Full Text] [Related]
19. [Short-term immunotherapy--a survey of current studies]. Rasp G; Klimek L Wien Med Wochenschr; 1999; 149(14-15):403-9. PubMed ID: 10584283 [TBL] [Abstract][Full Text] [Related]
20. The effect of anti-IgE treatment on in vitro leukotriene release in children with seasonal allergic rhinitis. Kopp MV; Brauburger J; Riedinger F; Beischer D; Ihorst G; Kamin W; Zielen S; Bez ; Friedrichs F; Von Berg A; Gerhold K; Hamelmann E; Hultsch ; Kuehr J J Allergy Clin Immunol; 2002 Nov; 110(5):728-35. PubMed ID: 12417881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]